162 related articles for article (PubMed ID: 31954759)
1. Commercial claims costs related to health care resource use associated with a diagnosis of peanut allergy.
Shaker M; Chalil JM; Tran O; Vlahiotis A; Shah H; King T; Green TD; Greenhawt M
Ann Allergy Asthma Immunol; 2020 Apr; 124(4):357-365.e1. PubMed ID: 31954759
[TBL] [Abstract][Full Text] [Related]
2. Health-care resource utilization associated with peanut allergy management under allergen avoidance among commercially insured individuals.
Meadows JA; Yu S; Hass SL; Guerin A; Latremouille-Viau D; Tilles SA
Allergy Asthma Proc; 2021 Jul; 42(4):333-342. PubMed ID: 34187625
[No Abstract] [Full Text] [Related]
3. The Impact of Allergy Specialty Care on Health Care Utilization Among Peanut Allergy Children in the United States.
Greenhawt M; Abrams EM; Chalil JM; Tran O; Green TD; Shaker MS
J Allergy Clin Immunol Pract; 2022 Dec; 10(12):3276-3283. PubMed ID: 35973525
[TBL] [Abstract][Full Text] [Related]
4. Economic burden of peanut allergy in pediatric patients with evidence of reactions to peanuts in the United States.
Blaiss MS; Meadows JA; Yu S; Robison DR; Hass SL; Norrett KE; Guerin A; Latremouille-Viau D; Tilles SA
J Manag Care Spec Pharm; 2021 Apr; 27(4):516-527. PubMed ID: 33470880
[No Abstract] [Full Text] [Related]
5. Health Care Utilization and Direct Costs Among Patients Diagnosed with Cluster Headache in U.S. Health Care Claims Data.
Choong CK; Ford JH; Nyhuis AW; Robinson RL; Aurora SK
J Manag Care Spec Pharm; 2018 Sep; 24(9):921-928. PubMed ID: 30156448
[TBL] [Abstract][Full Text] [Related]
6. Healthcare costs and utilization associated with muscle weakness diagnosis codes in patients with chronic obstructive pulmonary disease: a United States claims analysis.
Trantham L; Sikirica MV; Candrilli SD; Benson VS; Mohan D; Neil D; Joshi AV
J Med Econ; 2019 Apr; 22(4):319-327. PubMed ID: 30580639
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the healthcare resource use and the related financial costs of managing peanut allergy in the United Kingdom.
Scott LA; Berni TR; Berni ER; De Vries J; Currie CJ
Expert Rev Clin Immunol; 2019 Aug; 15(8):889-896. PubMed ID: 31305181
[No Abstract] [Full Text] [Related]
8. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
[TBL] [Abstract][Full Text] [Related]
9. Burden of illness and costs associated with eosinophilic granulomatosis with polyangiitis: evidence from a managed care database in the United States.
Bell CF; Blauer-Peterson C; Mao J
J Manag Care Spec Pharm; 2021 Sep; 27(9):1249-1259. PubMed ID: 34165321
[No Abstract] [Full Text] [Related]
10. Economic burden of non-cystic fibrosis bronchiectasis in the first year after diagnosis from a US health plan perspective.
Joish VN; Spilsbury-Cantalupo M; Operschall E; Luong B; Boklage S
Appl Health Econ Health Policy; 2013 Jun; 11(3):299-304. PubMed ID: 23580074
[TBL] [Abstract][Full Text] [Related]
11. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Peanut Allergy Diagnosis in a US Health Care Claims Database (2011-2017).
Mahr TA; Lieberman JA; Haselkorn T; Damle V; Ali Y; Chidambaram A; Griffin NM; Sublett JW
J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1683-1694.e5. PubMed ID: 33346150
[TBL] [Abstract][Full Text] [Related]
13. Burden of illness among patients with dementia-related psychosis.
Frazer M; Abler V; Halpern R; Skoog B; Rashid N
J Manag Care Spec Pharm; 2021 Mar; 27(3):367-378. PubMed ID: 33645238
[No Abstract] [Full Text] [Related]
14. The Direct Cost of Managing a Rare Disease: Assessing Medical and Pharmacy Costs Associated with Duchenne Muscular Dystrophy in the United States.
Thayer S; Bell C; McDonald CM
J Manag Care Spec Pharm; 2017 Jun; 23(6):633-641. PubMed ID: 28530521
[TBL] [Abstract][Full Text] [Related]
15. Health care resource utilization and cost of severe hypoglycemia treatment in insulin-treated patients with diabetes in the United States.
Bajpai S; Wong-Jacobson S; Liu D; Mitchell B; Haynes G; Syring K; Ali AK; Chinthammit C
J Manag Care Spec Pharm; 2021 Mar; 27(3):385-391. PubMed ID: 33645242
[No Abstract] [Full Text] [Related]
16. Cost of epilepsy-related health care encounters in the United States.
Borghs S; Beaty S; Parekh W; Kalilani L; Boudiaf N; Loewendorf A
J Manag Care Spec Pharm; 2020 Dec; 26(12):1576-1581. PubMed ID: 33103619
[No Abstract] [Full Text] [Related]
17. Health Care Resource Utilization and Costs Among Adults with Atopic Dermatitis in the United States: A Claims-Based Analysis.
Drucker AM; Qureshi AA; Amand C; Villeneuve S; Gadkari A; Chao J; Kuznik A; Bégo-Le-Bagousse G; Eckert L
J Allergy Clin Immunol Pract; 2018; 6(4):1342-1348. PubMed ID: 29174063
[TBL] [Abstract][Full Text] [Related]
18. The High Direct Medical Costs of Prader-Willi Syndrome.
Shoffstall AJ; Gaebler JA; Kreher NC; Niecko T; Douglas D; Strong TV; Miller JL; Stafford DE; Butler MG
J Pediatr; 2016 Aug; 175():137-43. PubMed ID: 27283463
[TBL] [Abstract][Full Text] [Related]
19. Clinical and economic burden of peripheral T-cell lymphoma in commercially insured patients in the United States: findings using real-world claims data.
Burudpakdee C; Lin HM; Wang W; Seetasith A; Zhu Y; Bonthapally V; Carson KR
J Med Econ; 2016 Oct; 19(10):965-72. PubMed ID: 27152635
[TBL] [Abstract][Full Text] [Related]
20. Healthcare Resource Use and Costs Associated with Opioid Initiation Among Patients with Newly Diagnosed Endometriosis with Commercial Insurance in the USA.
Estes SJ; Soliman AM; Zivkovic M; Chopra D; Zhu X
Adv Ther; 2020 Jun; 37(6):2777-2791. PubMed ID: 32399813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
